Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Asahi Kasei Corporation
  6. Summary
    3407   JP3111200006

ASAHI KASEI CORPORATION

(3407)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
06/08/2021 06/09/2021 06/10/2021 06/11/2021 06/14/2021 Date
1275 1259 1266 1253.5 1255 Last
3100800 2437200 2001300 3054200 1309500 Volume
+0.35% -1.25% +0.56% -0.99% +0.12% Change
Financials
Sales 2021 2 090 B 18 977 M 18 977 M
Net income 2021 78 974 M 717 M 717 M
Net Debt 2021 445 B 4 040 M 4 040 M
P/E ratio 2021 21,6x
Yield 2021 2,71%
Sales 2022 2 300 B 20 886 M 20 886 M
Net income 2022 147 B 1 338 M 1 338 M
Net Debt 2022 408 B 3 706 M 3 706 M
P/E ratio 2022 11,8x
Yield 2022 2,74%
Capitalization 1 741 B 15 832 M 15 812 M
EV / Sales 2021 1,05x
EV / Sales 2022 0,93x
Nbr of Employees 40 689
Free-Float 95,5%
More Financials
Company
Asahi Kasei Corporation est une société holding organisée autour de 4 pôles d'activités : - fabrication de produits chimiques (50.8% du CA) : ammoniac, soude caustique, résines synthétiques, caoutchouc synthétique, enduits, additifs, etc. Le groupe développe également une activité de production de fibres textiles, de matériels et de composants électroniques ; - développement et vente de logements (32.7%). En... 
More about the company
Ratings of Asahi Kasei Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about ASAHI KASEI CORPORATION
06/14ASAHI KASEI  : and Nara Medical University Confirm 226 nm UVC LED Efficacy Again..
BU
06/02Scandion Oncology appoints Johnny Stilou as new CFO
AQ
05/13ASAHI KASEI  : Fiscal 2020 Financial Results
PU
05/13Nikkei 225 Down 2.5% in Global Equities Slump
MT
05/13ASAHI KASEI  : Consolidated Results for Fiscal 2020
PU
04/27OSE Immunotherapeutics Licenses Investigational Transplant Drug to Asahi Kei ..
MT
04/25ASAHI KASEI  : Renews Membership in Business Call to Action Led by United Nation..
BU
04/20ASAHI KASEI  : Medical Bioprocess Affiliate Opens in China
BU
04/14Japan's new battery industry group to seek increased gov't support
RE
03/30ASAHI KASEI CORPORATION : Ex-dividend day for final dividend
FA
03/09ASAHI KASEI  : ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to S..
BU
02/16PRESS RELEASE : Basilea reports strong 2020 -2-
DJ
02/09ASAHI KASEI  : Attribute Net Income Falls 24% in April-December 2020
MT
01/29ELI LILLY AND COMPANY  : - Lilly and Asahi Kasei Pharma Announce License Agreeme..
AQ
01/25Nikkei 225 Up 0.7% on Wall Street Cues, Corporate Buybacks
MT
More news
News in other languages on ASAHI KASEI CORPORATION
06/01SEMI-CONDUCTEURS : le Japon officialise un projet de recherche avec TSMC
04/27OSE IMMUNOTHERAPEUTICS  : en hausse après un accord de licence
04/27Les valeurs à suivre aujourd'hui à la Bourse de Paris Mardi 27 avril 2021
04/27OSE IMMUNOTHERAPEUTICS  : A suivre aujourd'hui
04/26Les valeurs à suivre demain à la Bourse de Paris Mardi 27 avril 2021
More news
Chart ASAHI KASEI CORPORATION
Duration : Period :
Asahi Kasei Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASAHI KASEI CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 1 306,00 JPY
Last Close Price 1 255,00 JPY
Spread / Highest target 23,5%
Spread / Average Target 4,06%
Spread / Lowest Target -12,4%
EPS Revisions
Managers and Directors
NameTitle
Hideki Kobori Executive President & Representative Director
Koshiro Kudo Head-Finance, Accounting & Investor Relations
Masami Takenaka General Manager-Research & Development
Nobuyuki Kakizawa Head-Risk, Compliance, Legal & General Affairs
Masumi Shiraishi Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORPORATION19.01%15 832
BASF SE4.31%75 005
SHIN-ETSU CHEMICAL CO., LTD.4.79%69 917
DUPONT DE NEMOURS, INC.16.06%43 918
ROYAL DSM N.V.7.74%31 498
EVONIK INDUSTRIES AG6.03%15 947